Sexually transmitted diseases other than human immunodeficiency virus infection in older adults

Clinical Infectious Diseases

Volumn 36, Issue 5, 2003, Pages 609-614

  Calvet, Helene M ^a,b  

^a Long Beach Department of Health and Human Services   (United States)

^b CA STD/HIV Prev Training Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AZITHROMYCIN; BENZATHINE PENICILLIN; CEFIXIME; CEFTRIAXONE; CIPROFLOXACIN; DOXYCYCLINE FOSFATEX; ERYTHROMYCIN; ERYTHROMYCIN ETHYLSUCCINATE; FAMCICLOVIR; LEVOFLOXACIN; METRONIDAZOLE; OFLOXACIN; PENICILLIN G; PROBENECID; PROCAINE PENICILLIN; SPECTINOMYCIN; TETRACYCLINE; VALACICLOVIR;

AGING; CANDIDIASIS; CHLAMYDIASIS; CLINICAL FEATURE; DISEASE COURSE; GONORRHEA; HERPES SIMPLEX; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; INFECTION RATE; INFECTION RISK; LABORATORY TEST; NEUROSYPHILIS; PRIORITY JOURNAL; REVIEW; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; SYPHILIS; TRICHOMONIASIS; VAGINITIS;

CHLAMYDIA INFECTIONS; FEMALE; GONORRHEA; HERPES SIMPLEX; HIV INFECTIONS; HUMANS; PAPILLOMAVIRUS INFECTIONS; PRACTICE GUIDELINES; SEXUALLY TRANSMITTED DISEASES; SYPHILIS; VAGINITIS;

EID: 0037370080     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/367892     Document Type: Review

References (24)

1. Centers for Disease Control and Prevention (CDC). Sexually transmitted disease surveillance 2000. Atlanta: US Department of Health and Human Services, CDC, 2001.
2. Dunn ME, Cutler N. Sexual issues in older adults. AIDS Patient Care STDs 2000; 14:67-9.
3. Pfizer Web site. Available at http://www.pfizer.com/main.html. Accessed 24 January 2003.
4. Stall R, Catania J. AIDS risk behaviors among late middle-aged and elderly Americans. Arch Intern Med 1994; 154:57-63.
5. Murphree DD, DeHaven MJ. Does grandma need condoms? Condom use among women in a family practice setting. Arch Fam Med 1995; 4:233-8.
6. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2002. MMWR Morb Mortal Wkly Rep 2002; 51(RR-6):1-78.
7. Black CM. Current methods of laboratory diagnosis of Chlamydia trachomatis infections. Clin Microbiol Rev 1997; 10:160-84.
8. Somani J, Bhullar VB, Workowski KA, Farshy CE, Black CM. Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure. J Infect Dis 2000; 181:1421-7.
9. Centers for Disease Control and Prevention. Increases in fluoroquinolone-resistant Neisseria gonorrhoeae - Hawaii and California, 2001. MMWR Morb Mortal Wkly Rep 2002; 51:1041-4.
10. Hook EW III, Marra CM. Acquired syphilis in adults. N Engl J Med 1992; 326:1060-9.
11. Swartz MN, Healy BP, Musher DM. Late syphilis. In: Holmes KK, Spading PF, Mardh P-A, et al., eds. Sexually transmitted diseases, 3rd ed. US: McGraw-Hill, 1999:487-509.
12. Muic V, Ljubicic M, Vodopija I. Bayes' theorem-based assessment of VDRL syphilis screening miss rates. Sex Transm Dis 1999; 26:12-6.
13. Fleming DT, McQuillian GM, Johnson RE, et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 1997; 337:1105-1.
14. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med 1997; 102 (5A):3-8.
15. Beutner KR, Ferenczy A. Therapeutic approaches to genital warts. Am J Med 1997; 102 (5A):28-37.
16. Cornelison TL, Montz FJ, Bristow RE, Chou B, Bovicelli A, Zeger SL. Decreased incidence of cervical cancer in Medicare-eligible women. Obstet Gynecol 2002; 100:79-86.
17. Gostout BS, Podratz KC, McGovern RM, Persing DH. Cervical cancer in older women: a molecular analysis of human papillomavirus types, HLA types and p53 mutations. Am J Obstet Gynecol 1998; 179:56-61.
18. Paley PJ. Screening for the major malignancies affecting women: current guidelines. Am J Obstet Gynecol 2001; 184:1021-30.
19. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002; 287:2114-9.
20. Wright TC Jr, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ. 2001 Consensus guidelines for the management of women with cervical cytological abnormalities. JAMA 2002; 287:2120-9.
21. Koonings PP, Price JH. Evaluation of atypical glandular cells of undetermined significance: is age important? Am J Obstet Gynecol 2001; 184:1457-9.
22. Spinillo A, Bernuzzi AM, Cevini C, Gulminetti R, Luzi S, De Santolo A. The relationship of bacterial vaginosis, Candida, and Trichomonas infection to symptomatic vaginitis in postmenopausal women attending a vaginitis clinic. Maturitas 1997; 23:253-60.
23. Hillier SL, Lau RJ. Vaginal microflora in postmenopausal women who have not received estrogen replacement therapy. Clin Infect Dis 1997; 25(Suppl 2):S123-6.
24. Dragsted DM, Farholt S, Lind I. Occurrence of trichomoniasis in women in Denmark, 1967-1997. Sex Transm Dis 2001; 28:326-9.